Your browser doesn't support javascript.
loading
Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
Mukherjea, Debashree; Dhukhwa, Asmita; Sapra, Amit; Bhandari, Priyanka; Woolford, Katlyn; Franke, Jacob; Ramkumar, Vickram; Rybak, Leonard.
Afiliación
  • Mukherjea D; Department of Otolaryngology, SIU School of Medicine , Springfield, IL, USA.
  • Dhukhwa A; Springfield Combined Laboratory Facility, Novear Therapeutics LLC ., Springfield, IL, USA.
  • Sapra A; Department of Internal Medicine, SIU School of Medicine , Springfield, IL, USA.
  • Bhandari P; Department of Internal Medicine, SIU School of Medicine , Springfield, IL, USA.
  • Woolford K; Department of Otolaryngology, SIU School of Medicine , Springfield, IL, USA.
  • Franke J; Department of Otolaryngology, SIU School of Medicine , Springfield, IL, USA.
  • Ramkumar V; Department of Pharmacology, SIU School of Medicine , Springfield, IL, USA.
  • Rybak L; Department of Otolaryngology, SIU School of Medicine , Springfield, IL, USA.
Expert Opin Drug Metab Toxicol ; 16(10): 965-982, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32757852
INTRODUCTION: Cisplatin is a highly effective chemotherapeutic agent against a variety of solid tumors in adults and in children. Unfortunately, a large percentage of patients suffer permanent sensorineural hearing loss. Up to 60% of children and at least 50% of adults suffer this complication that seriously compromises their quality of life. Hearing loss is due to damage to the sensory cells in the inner ear. The mechanisms of cochlear damage are still being investigated. However, it appears that inner ear damage is triggered by reactive oxygen species (ROS) formation and inflammation 34. AREAS COVERED: We discuss a number of potential therapeutic targets that can be addressed to provide hearing protection. These strategies include enhancing the endogenous antioxidant pathways, heat shock proteins, G protein coupled receptors and counteracting ROS and reactive nitrogen species, and blocking pathways that produce inflammation, including TRPV1 and STAT1 36. EXPERT OPINION: Numerous potential protective agents show promise in animal models by systemic or local administration. However, clinical trials have not shown much efficacy to date with the exception of sodium thiosulfate. There is an urgent need to discover safe and effective protective agents that do not interfere with the efficacy of cisplatin against tumors yet preserve hearing 151.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Platino / Ototoxicidad / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Animals / Child / Humans Idioma: En Revista: Expert Opin Drug Metab Toxicol Asunto de la revista: METABOLISMO / TOXICOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Platino / Ototoxicidad / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Animals / Child / Humans Idioma: En Revista: Expert Opin Drug Metab Toxicol Asunto de la revista: METABOLISMO / TOXICOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido